Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen-Insensitive Prostatic Cancer”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableStudy completedNCT02398526
What this trial is testing

Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases

Who this might be right for
Castration-Resistant Prostatic Cancer
Bayer 363
Not applicableUnknownNCT04833517
What this trial is testing

Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)

Who this might be right for
Prostate Cancer MetastaticCastration Resistant Prostatic CancerAdvanced Prostate Carcinoma
Universität des Saarlandes 500
Testing effectiveness (Phase 2)Ended earlyNCT05551117
What this trial is testing

Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors

Who this might be right for
Castration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more
MacroGenics 192
Testing effectiveness (Phase 2)Study completedNCT00450619
What this trial is testing

153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 44
Early research (Phase 1)Study completedNCT05293496
What this trial is testing

MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCastration-Resistant Prostatic CancerMalignant Melanoma+4 more
MacroGenics 31
Testing effectiveness (Phase 2)Ended earlyNCT01020305
What this trial is testing

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerProstatic NeoplasmsCastrate-resistant Prostate Cancer (CRPC)+3 more
Sandy Srinivas 5
Not applicableTemporarily Not AvailableNCT06033001
What this trial is testing

Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Castration-Resistant Prostatic Cancer
Lantheus Medical Imaging
Large-scale testing (Phase 3)Active Not RecruitingNCT03748641
What this trial is testing

Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

Who this might be right for
Castration-Resistant Prostatic Cancer
Janssen Research & Development, LLC 765
Testing effectiveness (Phase 2)Study completedNCT03248570
What this trial is testing

Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects

Who this might be right for
Castration Resistant Prostatic CancerMetastatic Prostate Cancer
University of California, San Francisco 26
Testing effectiveness (Phase 2)Study completedNCT00928174
What this trial is testing

Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Queen's Medical Center 27
Testing effectiveness (Phase 2)Looking for participantsNCT07258407
What this trial is testing

A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostatic Cancer
T.O.A.D. Oncology SA 180
Early research (Phase 1)Ended earlyNCT04404140
What this trial is testing

A Study Evaluating The Safety, Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Who this might be right for
Castration-Resistant Prostatic Cancer
Hoffmann-La Roche 6
Not applicableUnknownNCT04126915
What this trial is testing

Precise Therapy for mCRPC Patients Through Whole Exome Sequencing(PTtWES)

Who this might be right for
Castration-Resistant Prostatic Cancer
Yinghao Sun 200
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Testing effectiveness (Phase 2)Study completedNCT05848011
What this trial is testing

Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Androgen-Independent Prostatic CancerAndrogen-Independent Prostatic NeoplasmsProstate Cancer Recurrent+6 more
MacroGenics 154
Testing effectiveness (Phase 2)WithdrawnNCT05191017
What this trial is testing

Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC

Who this might be right for
Prostate CancerProstatic CancerCancer of Prostate+5 more
Nuvation Bio Inc.
Early research (Phase 1)Study completedNCT00629057
What this trial is testing

A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer

Who this might be right for
Androgen-insensitive Prostate Cancer
Bavarian Nordic 24
Testing effectiveness (Phase 2)Study completedNCT01171729
What this trial is testing

Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer

Who this might be right for
Prostatic Cancer
Samsung Medical Center 12
Testing effectiveness (Phase 2)Ended earlyNCT01450683
What this trial is testing

Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

Who this might be right for
Prostate CancerProstatic NeoplasmsCastrate-resistant Prostate Cancer (CRPC)+3 more
Stanford University 4
Early research (Phase 1)Active Not RecruitingNCT04597411
What this trial is testing

Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Endocyte 101
Next Page